RecruitingNCT04284189

Aftercare of Childhood Cancer Survivors in Switzerland

Aftercare of Childhood Cancer Survivors in Switzerland - the ACCS Switzerland Project


Sponsor

Kantonsspital Aarau

Enrollment

140 participants

Start Date

Feb 12, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort study designed to investigate transition of follow-up care from pediatric oncology to adult care in a prospective and longitudinal way. The investigators collect data on preferences and expectations for follow-up care and transition to adult care by questionnaires in adolescent and young adult survivors of childhood cancer.


Eligibility

Min Age: 16 Years

Inclusion Criteria6

  • -year survivor of childhood cancer
  • Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)
  • Age at diagnosis <18 years
  • Age at study ≥16 years
  • At study start in follow-up care at one of the three pediatric oncology centers (group before transition) or transitioned not before 2014 (group after transition).
  • Written informed consent

Exclusion Criteria5

  • Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)
  • <5 years after therapy of a relapse or palliative situation
  • Severe cognitive impairment, which makes it impossible to complete the questionnaire independently
  • Insufficient knowledge of the German language
  • Informed consent form not signed

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERTransition model

Transition of follow-up care of childhood cancer survivors to adult care


Locations(3)

Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau

Aarau, Switzerland

Division of Oncology/ Hematology, University Children's Hospital Basel

Basel, Switzerland

Division of Oncology/ Hematology, Department of Pediatrics, Kantonsspital Lucerne

Lucerne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04284189


Related Trials